logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

FeiYada: Net profit in the first half of 2025 was 82.4455 million yuan, a year-on-year decrease of 43.97%.

date
22/08/2025
Feiyada announced that its operating income in the first half of 2025 was 1.784 billion yuan, a year-on-year decrease of 14.08%; net profit was 82.4455 million yuan, a year-on-year decrease of 43.97%. The company adheres to the principle of high-quality development, continues to focus on the watch business, and accelerates the development of strategic emerging industries.
Latest
2 m ago
CRRC Corporation Limited (01766.HK) announced its interim results, with a net profit attributable to the owners of the company of 7.246 billion yuan, an increase of 72.48% year-on-year.
3 m ago
Zhejiang Orient: Net profit attributable to parent company in the first half of the year was 407 million yuan, a year-on-year increase of 175.71%
3 m ago
Guoanda's fundraising situation for the first half of 2025: Intends to terminate the expansion project.
3 m ago
Purple Martin Food (603057.SH) released its performance for the first half of the year, with a net profit attributable to the parent company of 105 million yuan, a year-on-year decrease of 47.20%.
3 m ago
Sinoway Medical: The company's daily operations are normal, with no major adjustments in the market environment and industry policies. There are no undisclosed material events that should be disclosed by major shareholders, etc.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.